Calliditas Therapeutics Ab (CALT) Gross Profit Margin starting from the second quarter 2024 to second quarter 2023, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Calliditas Therapeutics Ab  (NASDAQ: CALT)


Calliditas Therapeutics Ab's Gross Profit Margin by quarter

Trends, Rankings, Statistics



CALT Gross Profit Margin (Jun 30 2024)
Q2
(Dec 31 2023)
Q4
0
Q3
0
Q2
0
Q1
Y / Y Revenue Change -
Seq. Revenue Change -59.49 %
Revenue In Millions $52.36
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 1013
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2024 Gross Profit Margin
Calliditas Therapeutics Ab recorded Gross Loss compared to Gross Profit achieved in the preceding quarter.


Observing second quarter 2024 results within Major Pharmaceutical Preparations industry 136 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
CALT's Gross Profit Margin second quarter 2024 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 137
Healthcare Sector # 233
Overall # 1013

Gross Profit Margin Statistics
High Average Low
98.11 % 96.73 % 95.36 %
(Dec 31 2022)   (Dec 31 2023)




Other Gross Profit Margin Profitability Ratios
CALT's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CALT's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CALT's Competitors
Gross Profit Margin Profit Margin for Calliditas Therapeutics Ab's Suppliers
Gross Profit Margin Profit Margin for CALT's Customers

You may also want to know
CALT's Annual Growth Rates CALT's Profitability Ratios CALT's Asset Turnover Ratio CALT's Dividend Growth
CALT's Roe CALT's Valuation Ratios CALT's Financial Strength Ratios CALT's Gross Profit Growth
CALT's Roa CALT's Inventory Turnover Ratio CALT's Growth Rates CALT's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2024, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2024 MRQ Gross ProfitJun 30 2024 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.